Search Results 361-370 of 17137 for nivolumab
IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the ...
Immunotherapy with antibodies, such as nivolumab and ipilimumab, may remove the brake on the body's immune system and may interfere with the ability of tumor ...
Nivolumab and hyaluronidase-nvhy (subcutaneous route) · Nivolumab/relatlimab-rmbw (intravenous route). Nix. Also known as. Permethrin (topical route). Nix ...
Patients with cHL should have failed at least one checkpoint inhibitor therapy before enrolling to the nivolumab combination cohort. Peripheral T-cell ...
How can exercise improve a chronic condition? · Arthritis. Exercise can ease pain, build muscle strength around joints and lessen joint stiffness. · Asthma. Often ...
The goal of the study is to identify immune responses (immune cell activation and suppression) following local ablation of liver tumors. A Study of Nivolumab ...
Nivolumab +/- ipilimumab and pembrolizumab; also available, strictly based on U.S. Food and Drug Administration approval. Based on recent negative data, and ...
In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...
Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no ... Rovalpituzumab Tesirine in Delta- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!